Global miRNA Market 2015-2019

Global miRNA Market 2015-2019 is a new market research publication announced by Reportstack. miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study expression of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. They are generally 17-27 nucleotides long and regulate post-transcriptional mRNA expression by binding to the 3’ untranslated region of the mRNA sequence, which results in translational suppression and gene silencing. miRNAs are involved in a wide range of biological processes, including apoptosis, cell cycle control, and several developmental processes such as stem cell differentiation, hypoxia, hematopoiesis, neurogenesis, insulin secretion, cardiac and skeletal muscle development, aging, cholesterol metabolism, viral replication, and immune responses. They can be used as therapeutics for the treatment of some severe diseases including cancer and genetic disorders by introducing specific miRNAs into diseased cells to silence the defective gene. 

The analysts forecast the Global miRNA market to grow at a CAGR of 13.36 percent over the period 2014-2019. The Global miRNA market can be divided into different segments based on application: miRNA Research, miRNA-based Diagnostics, and Therapeutics

The report, Global miRNA Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global miRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• APAC       

• EMEA

Key Vendors

• Affymetrix

• Agilent Technologies

• Exiqon

• Qiagen

• Thermo Fisher Scientific

Other Prominent Vendors

 • Alnylam Pharmaceuticals

• Aparna Biosciences

• Applied Biological Materials

• AstraZeneca Pharmaceuticals

• Biogen Idec

• Bio-Rad Laboratories

• F. Hoffmann-La Roche

• Firefly Bioworks

• Fluidigm

• Genecopoeia

• Genosensor

• Gensignia

• Glaxosmithkline

• Groove Biopharma

• HTG Molecular Diagnostics

• Idera Pharmaceuticals

• Illumina

• Integrated DNA Technologies

• InteRNA Technologies

• LC Sciences

• EMD Millipore

• Miltenyi Biotec

• miRagen Therapeutics

• Mirna Therapeutics

• Nanostring Technologies

• Norgen Biotek

• Novartis

• Origene Technologies

• Pfizer

• Phalanx Biotech

• Prolias Technologies

• Quark Pharmaceuticals

• Regulus Therapeutics

• Rosetta Genomics

• RXi Pharmaceuticals

• Sanofi

• Santaris Pharma (Acquired by Roche)

• Silence Therapeutics

• System Biosciences

• Takara Bio

• Tekmira Pharmaceuticals

• Theradiag

• WaferGen Biosystems

• Wako Pure Chemical Industries

Market Driver

• Increased Investment in miRNA-based Research and Drug Development

• For a full, detailed list, view our report

Market Challenge

• Delivery of miRNA-based Drugs

• For a full, detailed list, view our report

Market Trend

• Increased M&A

• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?To view the table of contents and know more details please visit Global miRNA Market 2015-2019